To compare the appearance of dietary protein-derived amino acids in plasma after ingestion of a milk protein powder with different levels of protein glycation in healthy young men.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Digestie en absorptie
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoint will be the appearance of milk protein-derived amino acids
in plasma over the full assessment period (6 h), as determined using stable
isotope tracer methodology.
Secondary outcome
To compare the impact of low versus high protein glycation on whole-body
protein kinetics (total rate of appearance, exogenous rate of appearance,
endogenous rate of appearance, rate of disappearance), whole-body protein
metabolism (synthesis, breakdown, oxidation, net balance), peak plasma lysine
concentration, overall plasma amino acid responses, plasma insulin-, and
glucose responses.
Background summary
Protein intake is an essential stimulus for muscle protein anabolism. The
muscle protein synthetic response to protein ingestion is mainly determined by
the post-prandial plasma amino acid response. Milk protein often undergoes
glycation during commonly applied milk processing procedures (Maillard
reaction). We have previously shown that glycated protein results in lower
postprandial amino acid levels. The level of protein glycation in processed
dairy products might therefore be an important modulator of the overall protein
quality of a product, and its ability to stimulate protein metabolism. However,
it has not yet been investigated if the glycation level of dietary protein
modulates its appearance in plasma as amino acids.
Study objective
To compare the appearance of dietary protein-derived amino acids in plasma
after ingestion of a milk protein powder with different levels of protein
glycation in healthy young men.
Study design
Double blinded, randomized cross-over study.
Intervention
All subjects will perform two experiments in a double-blinded, randomized
order: ingest 40 g of milk protein with 5% glycation level in 600 mL water, or
40 g of milk protein with 50% glycation level in 600 mL water. After ingestion,
blood samples will be taken at regular intervals during a 6 hour period.
Study burden and risks
The burden and risks with participation are small. A DEXA scan will be done to
assess body composition, where the level of radiation is very low compared to
the background radiation level in the Netherlands. Furthermore, we will ask the
participants to fill out a medical questionnaire. Insertion of the catheters
during the test day is comparable to a blood draw and could result in a small
hematoma. We will take 15 blood samples during the experimental period. The
total amount of blood we draw (150 mL each test day) is much less than the
amount of a blood donation (500 mL) and will be completely restored in
approximately 1 month. Participants will come to the university three times: 1
screening (~1h) and 2 experimental days (~8.5h each). On the experimental test
days, the subjects will be asked to remain fasted (with the exception of the
experimental drinks). In addition, subjects will be asked in the two days prior
to the test days not to perform any type of intense physical activity and to
avoid consuming caffeine and alcohol in the 12h and 24h prior to the test days,
respectively. Participants will be asked to record their nutritional intake and
daily activities in the two days prior to the experimental test days. There is
no direct benefit to the participant, only their contribution to the scientific
knowledge on the impact of protein glycation on protein digestion and
absorption. The milk protein supplements are produced according to food safety
standards and are safe for human use.
Universiteitssingel 50
Maastricht 6229 ER
NL
Universiteitssingel 50
Maastricht 6229 ER
NL
Listed location countries
Age
Inclusion criteria
- Males
- Aged between 18-35 years
- Healthy, recreationally active (participating in recreational sports
activities >= 1 and <= 6 h per week, with a maximum of 2 h resistance-type
exercise)
- 18.5 <= BMI <= 30 kg/m2
- No physical limitations (i.e. able to perform all activities associated with
daily living in an independent manner).
Exclusion criteria
- Smoking
- Lactose intolerant or allergies to milk proteins
- Musculoskeletal disorders
- Metabolic disorders
- Use of any medications known to affect protein metabolism (i.e.
corticosteroids, non-steroidal anti-inflammatories, or prescribed acne
medications).
- Chronic use of gastric acid suppressing medication or anti-coagulants
- Unstable weight over the last three months
- Diagnosed GI tract disorders or diseases
- Blood donation in the past 2 months
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL73994.068.22 |
Other | Registratie na goedkeuring METC |